{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:51:46Z","timestamp":1781632306697,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UKRI Strength in Places Fund","award":["SIPF00007\/1"],"award-info":[{"award-number":["SIPF00007\/1"]}]},{"name":"Medical Research Council","award":["MC_UU_00022\/2"],"award-info":[{"award-number":["MC_UU_00022\/2"]}]},{"name":"Medical Research Council","award":["MC_UU_00022\/2"],"award-info":[{"award-number":["MC_UU_00022\/2"]}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"crossref","award":["SPHSU17"],"award-info":[{"award-number":["SPHSU17"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"crossref","award":["SPHSU17"],"award-info":[{"award-number":["SPHSU17"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"crossref"}]},{"name":"British Heart Foundation Centre of Research Excellence","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver cirrhosis is one of the leading causes of mortality and morbidity in those of working age. Mortality from liver disease in the UK has continued to rise over the past decade. A significant proportion of patients presenting with decompensated liver disease have no prior diagnosis of liver disease despite multiple acute healthcare interactions providing opportunities for detection.<\/jats:p>\n                    <jats:p>We aimed to characterise patients presenting to unscheduled care with no known liver disease who subsequently had a liver related admission (DLD), and determine if a simple predictive score could identify those at high risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients attending unscheduled care in our health board between the beginning of 2018 and the end of 2020 were included with clinical follow up until end 2022. Exclusion criteria were known liver disease, early (&lt;\u20096 months) presentation with DLD or missing key laboratory data. A predictive model was developed based on demographic and laboratory parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Following exclusions, a group of 173,486 patients were included in our analysis, of whom 1,609 (0.9%) went on to have a DLD-related admission in the 5 year-follow up period. A model to predict future admission was developed based on Fib4 score (using the common blood tests Aspartate aminotransferase (AST), Alanine Transaminase (ALT) and platelet count), geographical deprivation decile, and sex. This model had a Harrell\u2019s C statistic of 0.78.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Unscheduled care presentations provide an opportunity to identify those at high risk of advanced liver disease and decompensation. It is likely these patients have undiagnosed liver disease at the time of presentation, and a model using simple laboratory and demographic data may aid detection in this setting of those at risk of future liver-related admission. External validation of this model is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-025-04534-2","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T01:46:40Z","timestamp":1768960000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying patients at high risk of decompensated liver disease through unscheduled care attendance data: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"R.","family":"Swann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lewsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dundas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Friday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Q. B.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. K.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Geue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"4534_CR1","unstructured":"Public Health Scotland. Scottish Public Health Observatory Update. Edinburgh: PHS; 2025."},{"key":"4534_CR2","unstructured":"Office for Health Improvement and Disparities. Liver Disease Profile 2024: update. London: OHID; 2024. Available from: https:\/\/www.gov.uk\/government\/statistics\/liver-disease-profile-april-2024-update\/liver-disease-profile-april-2024-update. Cited 2024 June 1."},{"key":"4534_CR3","doi-asserted-by":"publisher","unstructured":"The Lancet. Tackling liver disease in the UK: a Lancet Commission. Lancet. 2014;384(9958):1902. https:\/\/doi.org\/10.1016\/S0140-6736(14)61820-3.","DOI":"10.1016\/S0140-6736(14)61820-3"},{"key":"4534_CR4","doi-asserted-by":"publisher","unstructured":"Bodger K, Tapper M, Sterling P, et al. Outcomes of first emergency admissions for alcohol-related liver disease in England over a 10-year period: retrospective observational cohort study using linked electronic databases. BMJ Open. 2023;13(6):e076955. https:\/\/doi.org\/10.1136\/bmjopen-2023-076955.","DOI":"10.1136\/bmjopen-2023-076955"},{"key":"4534_CR5","doi-asserted-by":"publisher","unstructured":"Ratib S, Fleming KM, Crooks CJ, et al. One- and five-year survival estimates for people with cirrhosis of the liver in England, 1998\u20132009: a large population study. J Hepatol. 2014;60(2):282\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2013.09.027.","DOI":"10.1016\/j.jhep.2013.09.027"},{"key":"4534_CR6","doi-asserted-by":"publisher","unstructured":"Subhani M, Roberts ER, Baxter JM, et al. Alcohol-related liver disease mortality and missed opportunities in secondary care: a United Kingdom retrospective observational study. Drug Alcohol Rev. 2022;41(6):1331\u201340. https:\/\/doi.org\/10.1111\/dar.13495.","DOI":"10.1111\/dar.13495"},{"key":"4534_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105615","volume":"169","author":"J Zeng","year":"2023","unstructured":"Zeng J, Macdonald D, Durkin R, et al. Opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital. J Clin Virol. 2023;169:105615. https:\/\/doi.org\/10.1016\/j.jcv.2023.105615.","journal-title":"J Clin Virol"},{"key":"4534_CR8","doi-asserted-by":"publisher","unstructured":"8. Subhani M, Duffy E, Kerr HJ, et al. Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD): an open-label pragmatic feasibility randomised controlled trial. EClinicalMedicine. 2023;61:102069. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102069.","DOI":"10.1016\/j.eclinm.2023.102069"},{"key":"4534_CR9","doi-asserted-by":"publisher","unstructured":"Abeysekera KWM, Goulston MK, Ortiz-Kemp M, Samuel PR, Roderick HR, Yapp A, et al. Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):770\u201380. https:\/\/doi.org\/10.1016\/S2468-1253(22)00158-1.","DOI":"10.1016\/S2468-1253(22)00158-1"},{"issue":"1","key":"4534_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/HEP.0000000000001524","volume":"80","author":"F \u00c5berg","year":"2024","unstructured":"\u00c5berg F, Van Veldhoven J, Pet\u00e4j\u00e4 J. Combined use of the CLivD score and FIB-4 for prediction of liver-related outcomes in the population. Hepatology. 2024;80(1):163\u201372. https:\/\/doi.org\/10.1097\/HEP.0000000000001524.","journal-title":"Hepatology"},{"key":"4534_CR11","doi-asserted-by":"publisher","unstructured":"Montgomery C, Schofield S, et al. Prevalence and incidence of alcohol dependence: cross-sectional primary care analysis in Liverpool, UK. BMJ Open. 2023;13:e071024. https:\/\/doi.org\/10.1136\/bmjopen-2022-071024.","DOI":"10.1136\/bmjopen-2022-071024"},{"issue":"6","key":"4534_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/liv.15812","volume":"44","author":"AJ Archer","year":"2024","unstructured":"Archer AJ, Wang JM, Zhang WZ, Ghosh FH, Marshall MD, Ahmed AA, et al. Proactive case finding of alcohol-related liver disease in high-risk populations: a systematic review. Liver Int. 2024;44(6):1298\u2013308. https:\/\/doi.org\/10.1111\/liv.15812.","journal-title":"Liver Int"},{"issue":"3","key":"4534_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s10620-022-07731-1","volume":"68","author":"C Curran","year":"2023","unstructured":"Curran C, Priest M, Datta S, et al. Hepatocellular carcinoma risk scores predict patients under surveillance at low risk of benefit and high risk of harm. Dig Dis Sci. 2023;68(3):770\u20137. https:\/\/doi.org\/10.1007\/s10620-022-07731-1.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"4534_CR14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, APRICOT Clinical Investigators, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection\u2020\u2021. Hepatology. 2006;43(6):1317\u201325. https:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatology"},{"key":"4534_CR15","doi-asserted-by":"publisher","unstructured":"L\u00f3pez T\u00f3rrez SM, Rodr\u00edguez AC, Perez CR, et al. Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants. Front Nutr. 2024;11:1284509. https:\/\/doi.org\/10.3389\/fnut.2024.1284509.","DOI":"10.3389\/fnut.2024.1284509"},{"key":"4534_CR16","doi-asserted-by":"publisher","unstructured":"Moreno C, Mello S, Soriano G. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. J Hepatol. 2019;70(2):273\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.015.","DOI":"10.1016\/j.jhep.2018.10.015"},{"key":"4534_CR17","doi-asserted-by":"publisher","unstructured":"Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001. https:\/\/doi.org\/10.1007\/978-1-4757-3462-1.","DOI":"10.1007\/978-1-4757-3462-1"},{"issue":"4","key":"4534_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.\u00a0https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960229)15:4%3C;361::AID-SIM168%3E;3.0.CO;2-4.","journal-title":"Stat Med"},{"key":"4534_CR19","doi-asserted-by":"publisher","unstructured":"Lackner C, Spindelboeck W, Haybaeck J, Datz C, Puspok R, Trauner M, et al. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol. 2017;66(3):610\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2016.11.005.","DOI":"10.1016\/j.jhep.2016.11.005"},{"issue":"17","key":"4534_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","volume":"372","author":"MR Thursz","year":"2015","unstructured":"Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372(17):1619\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1412278.","journal-title":"N Engl J Med"},{"key":"4534_CR21","doi-asserted-by":"publisher","unstructured":"McDonald SA, Pal K, Bhattacharyya S, et al. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis. J Viral Hepat. 2020;27(3):270\u201380. https:\/\/doi.org\/10.1111\/jvh.13247.","DOI":"10.1111\/jvh.13247"},{"key":"4534_CR22","doi-asserted-by":"publisher","unstructured":"Gaspar R, Silva M, Louren\u00e7o R, et al. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis. 2019;51(8):1130-7. https:\/\/doi.org\/10.1016\/j.dld.2019.05.017.","DOI":"10.1016\/j.dld.2019.05.017"},{"key":"4534_CR23","doi-asserted-by":"publisher","unstructured":"Haghnejad V, Burke L, El Ouahabi S, Parker R, Rowe IA. Prediction models for liver decompensation in compensated advanced chronic liver disease: A systematic review. Hepatology. 2025. https:\/\/doi.org\/10.1097\/HEP.0000000000001359.","DOI":"10.1097\/HEP.0000000000001359"},{"key":"4534_CR24","doi-asserted-by":"publisher","unstructured":"Parkes J, Guha IN, Roderick P, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut. 2010;59(9):1245-51. https:\/\/doi.org\/10.1136\/gut.2009.203166.","DOI":"10.1136\/gut.2009.203166"},{"key":"4534_CR25","doi-asserted-by":"publisher","unstructured":"Kanwal F, Tapper EB, Ho C, et al. Development and validation of a risk prediction model for cirrhosis decompensation. Am J Gastroenterol. 2024;119(3):497\u2013504. https:\/\/doi.org\/10.14309\/ajg.0000000000002472.","DOI":"10.14309\/ajg.0000000000002472"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04534-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04534-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04534-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:53:04Z","timestamp":1781628784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04534-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4534"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04534-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Delegated research ethics approval was granted for linkage to National Health Service (NHS) patient data by the Local Privacy and Advisory Committee at NHS Greater Glasgow and Clyde.Cohorts and de-identified linked data were prepared by the West of Scotland Safe Haven Research Database at NHS Greater Glasgow and Clyde (IRAS Project ID 321198, REC reference 22\/WS\/1063).The NHSGGC Health Board Safe Haven database is a research resource that links health information datasets at the patient level, including routinely collected clinical primary and secondary care activity and national death registries. For the presented analyses, research datasets were linked in-house prior to being released to investigators in a fully anonymized format. The full dataset was accessed remotely via NHSGGC Safe Haven by designated members of the research team at the University of Glasgow, UK. Therefore, individual patient consent was not required. Internal reviews and ethical approvals were obtained as detailed above. The ethics board adheres to the principles of the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No identifiable patient data or images are included therefore this is not applicable to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}